top of page

Ron Melton, OD, FAAO

Ron Melton, OD, FAAO

Charlotte Eye Ear Nose & Throat Associates, P.A.

 

Education Anchor
Licensure Anchor
Certifications Anchor
Positions of Professional Service Anchor
Post Graduate Professional Short Courses Anchor
Clinical Research Activites Anchor
Presentations of Continuing Education Courses Anchor
Professional Publications
Achievements, Honors and Privileges
Professional Associations

EDUCATION:

O.D., Doctor of Optometry
Pennsylvania College of Optometry
Philadelphia, Pennsylvania
Graduation: May, 1981

B.S., Bachelor of Science in Integrated Biological Sciences
Pennsylvania College of Optometry
Philadelphia, Pennsylvania
Graduation: January, 1979

B.S., Bachelor of Science Biology and Business Administration
Greensboro College
Greensboro, North Carolina
Graduation: May, 1977

 

LICENSURE:

Indiana State Board of Optometry 
State of Indiana
July, 1981

North Carolina State Board of Examiners in Optometry
State of North Carolina
September, 1981

Oklahoma Board of Examiners in Optometry
State of Oklahoma
August, 1983

South Carolina Board of Examiners in Optometry
State of South Carolina
August, 1987


CERTIFICATIONS:

  • Successfully completed the National Board of Examiners in Optometry, April, 1981

  • Successfully completed the International Association of Boards of Examiners in Optometry Examination on "Treatment and Management of Ocular Disease", April, 1986
     

POSITIONS OF PROFESSIONAL SERVICE:

Charlotte Eye Ear Nose & Throat Associates, P.A.
Charlotte, North Carolina
May, 2000 to present

 

Nalle Clinic
Charlotte, North Carolina
May, 1986 to April, 2000

Private Practice
Oklahoma City and Tulsa, Oklahoma
September, 1984 to 1986

Primary Care Optometrist
Hawley Army Community Hospital
Indianapolis, Indiana
August, 1981 through August, 1984
 

POST GRADUATE PROFESSIONAL SHORT COURSES:

Armed Forces Institute of Pathology Course in Ophthalmic Pathology for Ophthalmologists, Washington, D.C. Fall, 1982

 

CLINICAL RESEARCH ACTIVITIES:

Investigator - An Active, Drug-Controlled, Double Masked, Multicenter Study Evaluating the Safety and Efficacy of 0.6% Norfloxacin Ophthalmic Solution vs. 0.3% Tobramycin Ophthalmic Solution in the Treatment of Patients with Acute Bacterial Infections of the External Eye and Adnexa, Protocol MK-366, Merck, Sharpe and Dohme Research Laboratories, 1986 - Completed.

Co-Investigator - Lovastatin Dose-Ranging Multicenter Study in Patients with Type II Hypercholesterolemia, Total Cholesterol 240-300 mg/dl with or without Other Risk Factors and with or without Evidence of Coronary Artery Disease, Protocol No. 022, Merck, Sharpe, and Dohme, 1987 - Completed.

Co-Investigator - A Double-Blind, Randomized Study of THERAFECTIN (amiprilose HC1) 6 grams/day Arthritis Withdrawn from their Nonsteroidal Anti-Inflammatory Drug Therapy, Protocol RA/10, Greenwich Pharmaceutical Inc., 1987 – Completed.

Co-Investigator - Tolrestat (AY-27,773) Prevention of Progression of Non-proliferative Diabetic Retinopathy: Effects on Retinal Morphology and Renal Function in Patients with Insulin-dependent Diabetes Mellitus, 1986 - Completed.

Investigator - A Multiple-Dose, Double-Masked, Parallel Active Treatment Controlled Multiclinic Study of 0.25% Timolol-in- GELRITE and 0.25% TIMOPTIC in Patients with Elevated Intraocular Pressure. Merck, Sharp & Dohme. 1992-Completed.

Co-Investigator - Evaluation of the Efficacy and Safety of Glimepiridie versus Glyburide in Subjects with Noninsulin-dependent Diabetes Mellitus, Protocol M/5220/0001 Upjohn. 1992 - Completed.

Investigator - The Long-term Safety and Ocular Hypotensive Efficacy of Brimonidine Tartrate 0.2% in Subjects with Open Angle Glaucoma or Ocular Hypertension. Allergan, Inc. 1992 - Completed.

Co-Investigator - A Randomized Study Comparing the Safety and Efficacy of Two Doses or Oral Ganciclovir to Intravenous Ganciclovir for the maintenance treatment of Cytomegalovirus Retinitis in People with Aids. Syntex. 1993 - Completed.

Investigator - A Multiple-Dose, Double-Masked, Active Treatment Controlled, Two-Period, Crossover Multiclinic Study of 0.5% Preservative-Free Timolol-in- GELRITE and 0.5% Timolol-in- GELRITE with Preservative in Patients with Elevated Intraocular Pressure. Merck, Sharp, & Dohme. 1994 - Completed.

Investigator - A Double-Blind Double-Dummy, Acyclovir Controlled, Parallel Group Study to Compare the Efficacy and Safety of Famciclovir with Acyclovir in the Treatment of Patients with Ophthalmic Zoster. Protocol # BRL 42810-098. SmithKline Beecham. 1994 - Present.

Investigator - A Parallel, Randomized, Double-Masked, Active Controlled, Multiclinic Study Comparing the Tolerability and Efficacy of 2% MK-507 Ophthalmic Solution and Orally Administered Acetazolomide in Patients with Ocular Hypertension or Glaucoma Receiving Concomitant Treatment with 0.5% Timolol Ophthalmic Solution. Protocol # 054-00. Merck, Sharp, & Dohme. 1995 - Completed.

Investigator - A Parallel, Randomized, Double-Masked Study Comparing the 0.5% Timolol/2.0% MK-507 Combination Ophthalmic Solution .I.D. to 0.5% Timolol Ophthalmic Solution B.I.D. or 2.0% MK-507 Ophthalmic Solution T.I.D. in Patients with Elevated Intraocular Pressure who are Inadequately Controlled on Timolol Alone. Protocol # 064. Merck, Sharp, & Dohme. 1995 Completed.

Investigator - A Four Month Multicenter, Double-Masked, Parallel Safety and Clinical Success Comparison of Brimonidine Tartrate 0.2% Versus Timolol 0.5% as Initial Therapy for Subjects with Open-Angle Glaucoma or Ocular Hypertension. Protocol # 190342-126- 00. Allergan, Inc. 1996 - Completed. 

Investigator - A Three-Month, Multicenter, Triple-Masked, Placebo-Controlled, Adjunctive Therapy Study of the Efficacy and Safety of TID Dosed AL-4862 1.0% Ophthalmic Suspension in the Treatment of Patients with Primary Open-Angle Glaucoma or Ocular Hypertension Maintained on Timolol Therapy. Protocol # C-95- 38. Alcon Laboratories, Inc. 1996 - Completed.

Investigator - A Parallel, Randomized, Double-Masked, Multicenter Study Comparing the Effect of Dorzolamide 2% to Pilocarpine 2% as Adjunctive Therapy to Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Patients with Elevated Intraocular Pressure. Protocol # 073-00. Merck & Co., Inc. 1996 - Completed.

Investigator - SEE3 Extended Wear Soft Contact Lens Research Study # 1000.06A - Lotrafilcon A Hydrophilic Contact Lens. CIBA Vision Corporation. 1996 - Completed.

Investigator - Safety and Efficacy of Ketotifen Fulmarate 0.025% Ophthalmic Solution Compared with Vehicle Placebo Control in the Allergen Challenge Model of Allergic Conjunctivitis. CIBA Vision (Novartis). 1998 - Completed.

Investigator – A Six-Month, Multicenter, Triple Masked, Placebo-Controlled Adjunctive Therapy Study of the Safety and Efficacy of AL-6221 0.0015%and AL-6221 0.004% Ophthalmic Solution in Patients with Open-Angle Glaucoma or Ocular Hypertension Maintained on TIMOPTIC 0.5%. Protocol # C-97- 73. Alcon Laboratories, Inc. 1998 - Completed.

Investigator – A Twelve-Week, Multicenter, Triple- Masked Study of the Safety and IOP-Lowering Efficacy of Levobetaxolol 0.5% Suspension Compared to TIMOPTIC 0.5% Solution in the Treatment of Patients with Open-Angle Glaucoma or Ocular Hypertension. Protocol # C-97- 67. Alcon Laboratories, Inc. 1998 – Completed

Investigator – Clinical Comparison of Acuvue Bifocal Contact Lenses vs. Lifestyle Xtra Soft Multifocal Contact Lenses. Johnson & Johnson Vision Products, Inc. (Vistakon). 1999 – Completed.

Investigator – A Randomized, 5 - Year Postmarketing Safety Study of Xalatan Compared to “Usual Care in Patients with Open Angle Glaucoma Glaucoma or Ocular Hypertension. Pharmacia & Upjohn. 1999 – Present.

Investigator – Evaluation of the Safety & Efficacy of Sterile Comfort Drops (AAC-002) When Compared to Boston Rewetting Drops (NOF002). Foresight Regulatory Strategies, Inc. 1999 – Completed.

Principal Investigator – Acuvue 8.8 Non-I/O Lenses From Different Lots, CR-9908. Johnson & Johnson Vision Products, Inc. (Vistakon). 2000 – Completed.

Principal Investigator – A Phase III Multicenter, Randomized, Double-Masked, Parallel Study to Compare the Safety and Efficacy of 0.3% Gatifloxacin Ophthalmic Solution with that of 0.3% Ofloxacin Ophthalmic Solution in the Treatment of Acute Bacterial Conjunctivitis (Protocol # SPCL-GFLX 3/02). Senju Pharmaceutical. 2000 – Closed.

Investigator – A Multicenter, Double-Masked, Randomized, Parallel Study of the Safety and Efficacy of 0.2% Brimonidine Tartrate/0.5% Timolol Combination Ophthalmic Solution Twice-Daily Compared with 0.5% Timolol Twice-Daily or Alphagan Three-Times- Daily for Three Months (Plus 9-Month, Masked Extension) in Patients with Glaucoma or Ocular Hypertension (Protocol # 190342-013T- 01). Allergan, Inc. 2000 – Present.

PRESENTATIONS OF CONTINUING EDUCATIONS COURSES, RESEARCH PAPERS AND SPECIAL LECTURES:

Lectured on the topics of pharmacology, ocular differential diagnoses, and medical management of eye diseases throughout the United States and internationally including Canada, Australia, Mexico, South Africa, and the United Kingdom

 

Professional Publications (Co-Authored with Randall K. Thomas, OD, MPH, FAAO):

  • "Pharmaceutical Agents Commonly Used to Treat Afflictions of the Eye and Adnexa", Southern Journal of Optometry, June, 1984.

  • "Pharmaceutical Agents Commonly Used to Treat Ocular Inflammations of the Eye and Adnexa", Southern Journal of Optometry, October, 1984. 

  • "Pharmaceutical Agents Commonly Used to Treat Infections / Inflammations of the Eye", Southern Journal of Optometry, October, 1984.

  • "How to Manage Viral Conjunctivitis", Optometric Management, June, 1991.

  • "Antiviral Drugs and Pharmacology" and "Conjunctival and Corneal Foreign Body Removal", Chapters in Clinical Optometric Pharmacology and Therapeutics, Editor: B.E. Onofrey, J.B. Lippincott Company, 1991. 

  • "Medical Management of Anterior Uveitis"; and "Grand Rounds Management of Corneal Abrasions", Chapters in Optometry Clinics - Anterior Segment Disease Update, Editor: J.G. Classe', Appleton and Lange, 1991.

  • “Dry Eye Syndrome and the Optometrist: Diagnosis and Treatment”, Publication from Roundtable Discussion, Allergan, 1991. 

  • “Use of Clinical Laboratory Testing in the Private Practice of Optometry”, Chapter in Optometry Clinics - Clinical Laboratory Testing, Editor: J.G. Classe', Appleton and Lange, 1992. 

  • “The Practical Guide to Therapeutic Drugs”, Optometric Management, May, 1992.

  • "A Review of Common Ophthalmic Antibacterial and Corticosteroid-Antibacterial Combination Drugs”, Chapter in Optometry Clinics - Ocular Pharmacology Update, Editor: J.G. Classe, Appleton and Lange, 1992.

  • “OD Dialogues: Ocular Surface Disease and Dry Eye Syndrome”, Publication from Roundtable Discussion, Allergan, 1992

  • "Pharmacology Questions”, Supplement to Optometric Management, January, 1993

  • “Does This Patient Have Glaucoma? Factors to Consider in Diagnosis and Management”, Eye Quest Magazine, January/February, 1993.

  • “When White and Quiet Turns Red and Angry - How to Relieve Contact Lens -Induced Inflammation”, Review of Optometry, April, 1993 

  • “2nd Annual Practical Guide to Therapeutic Drugs”, Optometric Management, May, 1993 

  • “Understanding Blepharitis”, Optometry Today, June, 1993.

  • “Take the Worry Out of Managing Uveitis”, Optometric Management, June, 1993

  • “Treatment of Blepharitis”, Optometry Today, July/August, 1993

  • “Pupillary Dilation: A View From the Trenches,” Guest Editorial, Journal of the American Optometric Association, September, 1993

  • “3rd Annual Practical Guide to Therapeutic Drugs”, Optometric Management, May 1994“Put Patient’s Interest First When Diagnosing Disease”,  Optometry Today, May, 1994

  • “A Practical Look at Clinical Dry Eye”, Optometry Today, May, 1994

  • “4th Annual Practical Guide to Therapeutic Drugs”, Optometric Management, May 1995

  • “Oral Medicines in Primary Eye Care”, Eye Quest Magazine, July/August, 1995

  • “Fluoroquinolones: A First-Line Treatment”, Primary Care Optometry News, September, 1995

  • “Understanding Today’s Glaucoma Medications”, Take Charge of Glaucoma Management - Supplement to Review of Optometry, September 15, 1995

  • “The Power of Prescribing”, Optometry Today - Eye Drug Update (Featured on Cover), October, 1995

  • “Nonspecific Conjunctivitis”, Optometry Today, October, 1995

  • “Open-Angle Glaucoma”, Optometry Today, October, 1995

  • “The 1996 Clinical Guide to Ophthalmic Drugs”, Review of Optometry, May 15, 1996

  • "linical Management of the Anterior Segment”, Optometry Today, August, 1996

  • “Clinical Grand Rounds of the World Wide Web”, Pacific University College of Optometry Center for Distributed Learning and Optometry Today, August, 1996

  • “Clinical Management of the Anterior Segment, Part II”, Optometry Today, September, 1996

  • “New Alpha-2 Agonist Offers Another Medical Alternative to Treat Glaucoma”, Primary Care Optometry News, November, 1996

  • “TPA Notebook”, Monthly Contribution to Primary Care Optometry News, 1997-1998

  • “Adenoviral Infections, Allergic Conjunctivitis, Bacterial Conjunctivitis, Chemical Keratoconjunctivitis: TPA Case Reports”, Practical Optometry, February, 1997

  • “Conjunctival and Corneal Foreign Body Removal”, Optometry Today, April, 1997

  • “Chlamydial Conjunctivitis in the Adult, Contact Blepharodermatitis, Corneal Abrasions: TPA Case Reports”, Practical Optometry, April, 1997

  • “The 1997 Clinical Guide to Ophthalmic Drugs”, Review of Optometry, May, 1997

  • “The Virtual Eyecare Clinic: Anterior Segment”, Lifelearn Eye Care CD-ROM Based Learning and Reference Modules for Eye Care Professionals, University of Waterloo School of Optometry, Ontario, Canada, May, 1997

  • “Corneal Foreign Bodies, Corneal Ulcers Versus Infiltrates: TPA Case Reports”, Practical Optometry, June, 1997

  • “Dry Eye Syndrome, Episcleritis: TPA Case Reports”, Practical Optometry, August, 1997

  • “How to Get More Out of Your Glaucoma Medications”, Review of Optometry, Take Charge of Glaucoma Management Supplement, September, 1997

  • “Herpes Simplex Keratitis, Herpes Zoster Ophthalmicus: TPA Case Reports”, Practical Optometry, October, 1997

  • “Forward”, in Drugs in Primary Eyecare, Editors: D.R. Woodard and R.B. Woodard, Appleton & Lange, 1997

  • “Hordeolum, Herpes Zoster: TPA Case Reports”, Practical Optometry, December, 1997

  • “Making All the Right Moves: Tried and True Strategies for Writing More Scripts”, Optometry Today, January-February, 1998

  • “Iritis and Iridocyclitis, Ocular Lymphangiectasis: TPA Case Reports”, Practical Optometry, February, 1998

  • “What’s the Best Medicine for This Glaucoma Patient?”, Review of Optometry, March, 1998

  • “Traumatic Hyphema, Parinaud’s Oculo-Glandular Syndrome: TPA Case Reports”, Practical Optometry, April, 1998

  • “Glaucoma Agents”, Section in Ocular Therapeutics Handbook: A Clinical Manual, Editors: B.E. Onofrey, L. Skorin, Jr., N.R. Holdeman, Lippincott-Raven, 1998

  • “Parinaud’s Oculo-Glandular Syndrome, Phlyctenular Keratoconjunctivitis: TPA Case Reports”, Practical Optometry, June, 1998

  • “The 1998 Clinical Guide to Ophthalmic Drugs”, Review of Optometry, June, 1998

  • “Superior Limbic Keratoconjunctivitis, Thygeson’s Superficial Punctate Keratopathy, Vernal Keratoconjunctivitis: TPA Case Reports”, August, 1998

  • “Blepharitis, Floppy Eyelid Syndrome: TPA Case Reports”, Practical Optometry, October, 1998

  • “Bell’s Palsy: TPA Case Report”, Practical Optometry, December, 1998

  • “Nonspecific Conjunctivitis: TPA Case Report”, Practical Optometry, February, 1999

  • “The Great Contact Lens Debate: What’s the Best Medicine for Ulcerative Keratitis?”, Review of Optometry, April, 1999 

  • “Fungal Corneal Infection: TPA Case Report”, Practical Optometry, June, 1999

  • "Optometric Medicine: Delivering the Whole Package”, Optometric Management, July, 1999

  • “The 1999 Clinical Guide to Ophthalmic Drugs”, Review of Optometry, July, 1999

  • “Ocular Rosacea: TPA Case Report”, Practical Optometry, August, 1999

  • “Dacryocystitis: TPA Case Report”, Practical Optometry, October, 1999

  • “Acute Corneal Hydrops, Neurotrophic Keratitis: TPA Case Reports”, Practical Optometry, December, 1999

  • “Dacryoadenitis: TPA Case Report”, Practical Optometry, February, 2000

  • “Glaucomatocyclitic Crisis: TPA Case Report”, Practical Optometry, April, 2000

  • “The 2000 Clinical Guide to Ophthalmic Drugs”, Review of Optometry, May, 2000

  • “Blocking the Allergic Cascade” Panel Discussion, Supplement to Optometric Management, May, 2000

  • “Trichotillomania: TPA Case Report”, Practical Optometry, June, 2000

  • “Soft Torics Made Simple”, Panel Discussion, Supplement to Contact Lens Spectrum, June, 2000

  • “New Anti-Infectives Under Development Will Boast Broader Spectrum Activity”, Panel Discussion, Primary Care Optometry News, July, 2000

 

ACHIEVEMENTS, HONORS AND PRIVILEGES:

  • Awarded the “Glaucoma Educator of the Year” by the American Academy of Optometry, in cooperation with Randall Thomas, O.D., 1997

  • Appointed as a member of the Medical Advisory Panel, Piedmont Healthcare Alliance, Charlotte, North Carolina, 1997 - 2000

  • Appointed as a member of the Editorial Board, Primary Care Optometry News, 1995 - Present

  • Appointed as a member of the Adjunct Faculty, State University of New York College of Optometry, 1993 - Present

  • Appointed as a member of the Adjunct Faculty, Pacific University College of Optometry, 1993 - Present

  • Appointed as a Consultant of the Council on Optometric Education by the American Optometric Association, 1993

  • Appointed as a Clinical Examiner for the North Carolina State Board of Examiners in Optometry, 1992

  • Appointed as a member of the Adjunct Faculty, Pennsylvania College of Optometry, 1988 - Present 

  • Consultant Item Writer for the National Board of Examiners in Optometry, 1986-1987

  • Awarded the William C. Ezell Award For the Best Article Based Upon a Lecture Given at the Southern Congress of Optometry, in cooperation with Randall Thomas, O.D. and Carson Cox, , O.D., M.Ed., 1985

  • Fellowship, American Academy of Optometry, 1984

  • Appointed as a Regional Consultant of the Council on Clinical Optometric Care by the American Optometric Association, 1984 – 1993

  • Recipient of the American Optometric Association's & Optometric Recognition Award; for excellence in continuing professional education, 1984

  • Selected as a participant of the Health Professions Scholarship Program of the United States Army during training at the Pennsylvania College of Optometry, 1978-1981

  • Selected to serve as a member of the Student Optometric Service to Haiti (S.O.S. H.) Team, 1981

  • Student member of the Admissions Committee for applicants to the Pennsylvania College of Optometry, 1977-1979

  • Who's Who Among Students in American Colleges and Universities, Greensboro College, 1977

  • Graduated from Greensboro College with Magna Cum Laude Honors, 1977

  • Wall Street Journal Award from the Business Department at Greensboro College, 1977

  • Selected as a Broyhill Free Enterprise Scholar by Broyhill Industries, 1973

  • Selected as "Mr. Senior" high school student of the year in North Carolina by Greensboro College and awarded an academic scholarship, 1973


PROFESSIONAL ASSOCIATIONS:

  • American Academy of Optometry

  • American Optometric Association

  • North Carolina Optometric Society

  • Tri-County District Optometric Society - North Carolina

  • Contact Lens Section - American Optometric Association

  • Council on Optometric Education -Consultant - American Optometric Association

bottom of page